GoldNApel FB Update!! GoldNApel 10/10/2013. Hi

New Post Public Reply Private Reply Replies (6) Message Board
on41greyst
GoldNApel FB Update!!

GoldNApel 10/10/2013.

Hi Everybody,

I have been carrying on a conversation with Chris on the facebook message feature. He recently inquired if we were still active because he hadn't heard from me for a few days, as we were quite busy. I wrote him a long reply and realized that it might be good to share it with everyone. Here it is:

Hi Chris,

Yes we are active and we have been working very hard. Sorry I was slow in replying. That time of the year! Harvest time for a strain of Cannatonic that yielded over 17% CBD several years back. Waiting for tests on this year's efforts. Hopefully we have the THC down to near nothing, but actually, it doesn't matter all that much anymore. We can now preserve all of the cannabinoids in their non-psychoactive form with the new technology that Dr. Apel has developed over the last year or so, and that we announced today.

The "game-changer" we talked about a while back is here. I really believe that our new Dharmanol preparation will enable a cancer patient to take 10 or more times the cannabinoids that are recommended in Simpson therapy, and there may well be no cancer that can stand up to this kind of treatment in an otherwise-healthy individual. Everything we have seen in this field of research indicates that this may well be true.

I will never claim a "cure" until we have some double-blind placebo-controlled tests of the type Dr. Abrams wants to do, if the government would ever give him some "official" cannabis oil to experiment with, but even a person with no formal education in science can go online, google keywords like "cannabis cancer" and do many hours of informative reading from reputable scientific sources.

I would think that anyone with an interest in what SK3 and BBio are doing would perform this simple task and see what the current research is saying. Even the staunchest skeptic, with a bit of reading and study, would likely agree that cannabinoid therapy is indeed a treatment for cancer that holds a great deal of promise for mankind. That is why I find it so hard to believe that there are those who try so hard to question everything that we are doing, and present all of our activities in the worst possible light on the message boards.

(By the way, I will scan the boards on a day such as today, but all of us are far too busy building our respective parts of this company to put much time and effort into the boards).

Several months ago I said that I would answer any questions here that I could from those who speculate on the message boards, and I appreciate your starting a conversation with me, but I have received very few questions.

The announcement today was just a part of where we see this going. We now have the capacity to remove the psychoactivity from the kind herb, and make it truly a kind medicine, for all of those in need of healing. There are several different delivery systems we are working on, as well as combinations with other healing herbs and supplements, providing Dharmanol-based medicines tailored specifically for a variety of the ailments that cannabinoid therapy has shown to be effective in treating.

Thanks again for the conversation. I will always do my best to keep a good dialogue going.

Dave

While I'm at it, let me clarify low-dose and high-dose Dharmanol. The low-dose tablets are designed for daily health maintenance with a total of 10 mg. of cannabinoids, consisting of 5 mg. CBD and 5 mg. mixed cannabinoid carboxylates (which have been stabilized in their non-psychoactive form), and an additional 5 mg of steam-extracted terpenes and terpenoids from a variety of strains of cannabis. (The terpenes help the cannabinoids bind to the receptors, enhancing the efficacy of the treatment). Also, the steam-extract allows the extraction and inclusion of many different elements of the kind herb which have demonstrated that so-called whole plant medicinals are much better than just the isolated elements, in many cases, and utilizing an extract from the widest variety of strains possible insures that we get some of the entire spectrum of whole-plant goodness.

The purpose of high-dose Dharmanol is to provide the body of a cancer patient with the equivalent of a Simpson dose, but without the psychoactivity or "high". A different delivery system is being prepared for utilizing Dharmanol in high doses for the treatment of serious illnesses, but it is not inconceivable for a person treating cancer to chew 8 low-dose Dharmanol tablets six times a day, which would give a Simpson-sized dose with no side effects, and, in strictly my own opinion, the safest and most promising experimental cancer treatment that is currently being studied in the world of cannabis science.

The ultimate hope for Dharmanol will come in mega-doses that exceed the Simpson norm many times. Simpson's recommended dose is about one ten-thousandth of the LD-50 for marijuana. (LD-50 is the amount of a drug that will kill half of the lab animals to which it is administered). Most cancer drugs are so harmful to the body that the effective dose is a large percentage of the size dose that will cause death.

With the huge ratio between the Simpson dose and the LD-50 for cannabis, there is opportunity to step up the dosage levels many times. The only reason this isn't done is because handling a full gram of strong cannabis oil daily is very difficult for many people, especially by those who have never experienced cannabis. Now that we have removed the psychoactivity and medicinalized the plant, we will soon see the results of people treating serious illnesses with many times the doses possible today.

Cannabis medicine works on both ends of the spectrum. Small daily doses will tune up the body's own endo-cannabinoid system, keeping one healthy. Large doses are doseage-dependent, meaning the more the better. University lab tests have shown that concentrated cannabis medicine, when applied to cancerous tissue, adjacent to healthy tissue, will directly kill the malignant cells, while simultaneously strengthening the healthy ones. Even though there are many other mechanisms that cannabis uses to fight disease, I find this one amazing, and indicative of the special energy that this wonderful plant holds.

Thanks!

Dave

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Citrine Finalizes Sale of Illinois Senior Living Asset

Updated Category News Views 13

Citrine's Strategic Exit from River Glen Every now and then, you see a company pull off something that makes you nod and say, "That was smart." Citrine Investment Group's sale of River Glen of St. Charles fits that bill. For those keeping tabs, this wasn't some quick flip—Citrine worked on the rock for a good while before cashing in. They secured River Glen back in...

Continue Reading
ScholarShare 529 Launches $50 Back-to-School Promo

Updated Category News Views 3

California Families Get a Boost With New 529 Plan Offer Everywhere you turn, it's 'back to school' mania right now, and ScholarShare 529 aims to ride that wave by sweetening the pot for parents ready to think ahead. So here's the gist—California's official college savings plan is handing out a $50 gift card for new accounts opened between now and September 30th. Setting...

Continue Reading
2026 CEE Awards Highlight Energy Innovation Leaders

Updated Category News Views 4

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

Continue Reading
Feeding Families Foundation Gains $121,500 for NYC Push

Updated Category News Views 6

Holy smokes, here comes some good news in the nonprofit corners! Feeding Families Foundation just got a hefty $121,500 boost from the Association of Contracting Plumbers of the City of New York Inc. This ain't just some pocket change; it's a full-fledged lifeline that helps them keep on delivering meals to parents who are practically living at their kid’s hospital...

Continue Reading
Jacob Walthour to Be Honored for Economic Leadership

Updated Category News Views 3

The Honoring of Leadership That Goes Beyond Business In a world where financial influence often feels like it funnels into the same familiar pockets, the news of Jacob Walthour Jr.'s upcoming recognition feels like a fresh breeze of change. The Alpha Phi Alpha's Alpha Alpha Lambda Chapter is rolling out the red carpet at its Centennial Gala for Walthour, throwing him into...

Continue Reading
Propensity Rockets to No. 70 on the 2026 Inc. 5000 List

Updated Category News Views 4

Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...

Continue Reading
Rosewood HK Tops Best Hotel List Again; Asia Shines

Updated Category News Views 4

Holding the Crown: Rosewood Hong Kong's Triumph When a single hotel keeps nabbing the top spot in the world's most prestigious rankings, it's worth taking a closer look. That's exactly what's happening with Rosewood Hong Kong, crowned the world's best once more in 2026—its second consecutive year at the pinnacle according to The 50 Best Hotels. Defining Luxury on a...

Continue Reading
Ransoms and Mega-Losses Surge in Cyber Claims Study

Updated Category News Views 4

Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...

Continue Reading
Finastra Recognized as 2026 Leader in Payment Platforms

Updated Category News Views 4

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

Continue Reading
Koogler's Sale to ALL4: A Game-Changer for the Southeast

Updated Category News Views 5

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Continue Reading

Top 5 Most Recently Viewed Articles

Legal Avenues for Investors in Tvardi Therapeutics – Action Now!

Updated Category News Views 226

Understanding the Investigation into Tvardi Therapeutics, Inc. Investors in Tvardi Therapeutics, Inc. (NASDAQ: TVRD) are currently facing a tumultuous time as investigation efforts ramp up concerning potential fraud. The firm investigating these claims, known for its dedication to shareholder rights, is looking into whether the Company made misleading statements that...

Continue Reading
Formula One Partners with LVMH for a Decade of Luxury

Updated Category News Views 111

Formula One's Landmark Partnership with LVMH Liberty Media's Formula One series has entered into an impressive 10-year partnership with the luxury group, LVMH Moet Hennessy Louis Vuitton SE. This exciting new collaboration is set to commence with the upcoming F1 season, paving the way for a range of premium hospitality options, exclusive activations, and limited-edition...

Continue Reading
Exploring Recent Trends in Humana Options Trading Activities

Updated Category News Views 106

Trends in Humana's Options Trading Recently, there has been a significant shift in the options trading landscape surrounding Humana. Large investors, often referred to as whales, have been adopting a noticeably bearish outlook. This trend indicates cautious sentiment in the marketplace that benefits from keen scrutiny. Understanding the Options History The options history...

Continue Reading
Maui Land & Pineapple Co Reports Impressive Growth in Q2 2025

Updated Category News Views 101

Maui Land & Pineapple Company Achieves Notable Growth Kapalua, Hawai‘i — Maui Land & Pineapple Company, Inc. (NYSE: MLP) has reported impressive financial results for the quarter ending June 30, showcasing a remarkable year-over-year growth which affirms the company's strategic vision. Financial Highlights of Second Quarter 2025 CEO Race Randle shared, "The Company's...

Continue Reading
McGrath RentCorp Unveils Third Quarter Financial Results Plans

Updated Category News Views 130

McGrath RentCorp's Q3 2024 financial results are set to drop post-market on October 24, 2024. This ain't just any report; it's a bellwether for how the company is navigating a competitive rental market. With their two primary divisions—Mobile Modular and TRS-RenTelco—investors are hungry for clarity on revenues and earnings per share (EPS). The desks will be watching...

Continue Reading